Flossbach Von Storch AG Purchases 90,396 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Flossbach Von Storch AG lifted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 7.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,354,742 shares of the medical research company's stock after purchasing an additional 90,396 shares during the quarter. Thermo Fisher Scientific accounts for approximately 3.3% of Flossbach Von Storch AG's investment portfolio, making the stock its 13th largest position. Flossbach Von Storch AG owned 0.35% of Thermo Fisher Scientific worth $719,084,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Savant Capital LLC lifted its holdings in shares of Thermo Fisher Scientific by 0.5% in the 4th quarter. Savant Capital LLC now owns 3,627 shares of the medical research company's stock valued at $1,997,000 after acquiring an additional 18 shares during the last quarter. Sugarloaf Wealth Management LLC boosted its holdings in shares of Thermo Fisher Scientific by 6.9% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 294 shares of the medical research company's stock worth $156,000 after purchasing an additional 19 shares during the period. Rosenberg Matthew Hamilton raised its holdings in Thermo Fisher Scientific by 3.7% during the 4th quarter. Rosenberg Matthew Hamilton now owns 526 shares of the medical research company's stock valued at $279,000 after buying an additional 19 shares during the period. Tsfg LLC boosted its stake in Thermo Fisher Scientific by 8.3% during the fourth quarter. Tsfg LLC now owns 249 shares of the medical research company's stock worth $132,000 after buying an additional 19 shares during the period. Finally, 1776 Wealth LLC raised its stake in shares of Thermo Fisher Scientific by 2.4% in the fourth quarter. 1776 Wealth LLC now owns 799 shares of the medical research company's stock valued at $440,000 after acquiring an additional 19 shares during the period. Hedge funds and other institutional investors own 89.23% of the company's stock.

Thermo Fisher Scientific Stock Down 1.3 %

NYSE TMO traded down $7.30 on Wednesday, hitting $547.25. The stock had a trading volume of 1,609,039 shares, compared to its average volume of 1,540,204. Thermo Fisher Scientific Inc. has a 52-week low of $415.60 and a 52-week high of $603.82. The business's fifty day moving average price is $571.57 and its 200 day moving average price is $527.01. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.75 and a quick ratio of 1.39. The stock has a market cap of $208.89 billion, a price-to-earnings ratio of 35.42, a price-to-earnings-growth ratio of 2.34 and a beta of 0.80.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last issued its quarterly earnings results on Wednesday, January 31st. The medical research company reported $5.67 earnings per share for the quarter, topping the consensus estimate of $5.64 by $0.03. The business had revenue of $10.89 billion during the quarter, compared to the consensus estimate of $10.73 billion. Thermo Fisher Scientific had a return on equity of 18.78% and a net margin of 13.99%. The company's quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter last year, the company earned $5.40 earnings per share. Equities research analysts anticipate that Thermo Fisher Scientific Inc. will post 21.52 earnings per share for the current year.

Thermo Fisher Scientific Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Friday, March 15th were paid a dividend of $0.39 per share. This is an increase from Thermo Fisher Scientific's previous quarterly dividend of $0.35. This represents a $1.56 annualized dividend and a dividend yield of 0.29%. The ex-dividend date was Thursday, March 14th. Thermo Fisher Scientific's payout ratio is presently 10.10%.

Wall Street Analyst Weigh In

TMO has been the subject of several analyst reports. TheStreet raised shares of Thermo Fisher Scientific from a "c+" rating to a "b-" rating in a research note on Friday, December 22nd. HSBC increased their target price on Thermo Fisher Scientific from $630.00 to $660.00 and gave the stock a "buy" rating in a research note on Wednesday. Sanford C. Bernstein reissued a "market perform" rating on shares of Thermo Fisher Scientific in a research note on Monday, January 8th. Raymond James lifted their price objective on shares of Thermo Fisher Scientific from $515.00 to $605.00 and gave the company an "outperform" rating in a report on Thursday, February 1st. Finally, Evercore ISI raised their target price on shares of Thermo Fisher Scientific from $575.00 to $610.00 and gave the stock an "outperform" rating in a research report on Thursday, April 4th. Five equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, Thermo Fisher Scientific currently has a consensus rating of "Moderate Buy" and a consensus target price of $604.69.

Insider Activity at Thermo Fisher Scientific

In related news, CEO Marc N. Casper sold 10,000 shares of the company's stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $597.98, for a total value of $5,979,800.00. Following the sale, the chief executive officer now owns 123,816 shares in the company, valued at $74,039,491.68. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, CEO Marc N. Casper sold 10,000 shares of the company's stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $597.98, for a total value of $5,979,800.00. Following the sale, the chief executive officer now owns 123,816 shares in the company, valued at $74,039,491.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Debora L. Spar sold 164 shares of Thermo Fisher Scientific stock in a transaction on Monday, February 12th. The shares were sold at an average price of $546.97, for a total transaction of $89,703.08. Following the completion of the transaction, the director now directly owns 1,207 shares of the company's stock, valued at approximately $660,192.79. The disclosure for this sale can be found here. Insiders have sold a total of 50,277 shares of company stock valued at $28,513,384 in the last ninety days. Company insiders own 0.32% of the company's stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.